European Journal of Vascular & Endovascular Surgery
Volume 31, Issue 5 , Pages 509-515 , May 2006

Inflammation and Chlamydia pneumoniae Infection Correlate with the Severity of Peripheral Arterial Disease

  • E.A. Kaperonis

      Affiliations

    • 2nd Department of Propedeutic Surgery, Laikon Hospital, Athens University Medical School, Athens, Greece
    • Corresponding Author InformationCorresponding author. Elias A. Kaperonis, MD, 85, G. Zografou Str., 15772 Athens, Greece.
    • ,
  • C.D. Liapis

      Affiliations

    • 2nd Department of Propedeutic Surgery, Laikon Hospital, Athens University Medical School, Athens, Greece
    • ,
  • J.D. Kakisis

      Affiliations

    • 3rd Department of Surgery, Attikon Hospital, Athens University Medical School, Athens, Greece
    • ,
  • D. Dimitroulis

      Affiliations

    • 2nd Department of Propedeutic Surgery, Laikon Hospital, Athens University Medical School, Athens, Greece
    • ,
  • V.G. Papavassiliou

      Affiliations

    • Vascular Surgery Department, Sismanogleion Hospital, Athens, Greece
    • ,
  • D. Perrea

      Affiliations

    • Laboratory of Experimental Surgery and Surgical Research ‘N Christeas’, Athens University Medical School, Athens, Greece
    • ,
  • A.G. Kostakis

      Affiliations

    • 2nd Department of Propedeutic Surgery, Laikon Hospital, Athens University Medical School, Athens, Greece

,Accepted 24 November 2005.

References 

  1. Osler W. Diseases of the arteries. In:  Osler W editors. Modern medicine: its practice and theory. Philadelphia: Lea and Febiger; 1908;p. 429–447
  2. Hanson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–1695
  3. Saikku P, Leinonen M, Matilla K, Ekman M-R, Nieminen MS, Makela PH, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2:983–986
  4. Engstrom G, Lind P, Hedblad B, Stavenow L, Janzon L, Lindgarde F. Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation. 2002;105(22):2632–2637
  5. Wolf SC, Mayer O, Jurgens S, Vonthein R, Schultze G, Risler T, et al. Chlamydia pneumoniae IgA seropositivity is associated with increased risk for atherosclerotic vascular disease, myocardial infarction and stroke in dialysis patients. Clin Nephrol. 2003;59(4):273–279
  6. Hiatt WR, Hirsch AT, Regensteiner JG, Brass EP. Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists. Circulation. 1995;92(3):614–621
  7. Diehm C, Schuster A, Allenberg JR, Darius H, Haberl R, Lange S, et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis. 2004;172:95–105
  8. Signorelli SS, Mazzarino MC, Di Pino L, Malaponte G, Porto C, Pennisi G, et al. High circulating levels of cytokines (IL-6 and TNF-α), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test. Vasc Med. 2003;8(1):15–19
  9. Linares-Palomino JP, Gutierrez J, Lopez-Espada C, de Dios Luna J, Ros E, Maroto C. Genomic, serologic and clinical case–control study of Chlamydia pneumoniae and peripheral artery occlusive disease. J Vasc Surg. 2004;40:359–366
  10. Krayenbuehl P-A, Wiesli P, Maly FE, Vetter W, Schulthess G. Progression of peripheral arterial occlusive disease is associated with Chlamydia pneumoniae seropositivity and can be inhibited by antibiotic treatment. Atherosclerosis. 2005;179:103–110
  11. Grayston JT, Kronmal RA, Jackson LA, Parisi AF, Muhlestein JB, Cohen JD, et al. Azithromycin for the secondary prevention of coronary events. N Engl J Med. 2005;352:1637–1645
  12. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97:425–428
  13. Muscari A, Martignani C, Bastagli L, Poggiopollini G, Tomassetti V, Baldini L, et al. A comparison of acute phase proteins and traditional risk factors as markers of combined plaque and intima-media thickness and plaque density in carotid and femoral arteries. Eur J Vasc Endovasc Surg. 2003;26:81–87
  14. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001;285(19):2481–2485
  15. Mayr M, Kiechl S, Willeit J, Wick G, Xu Q. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation. 2000;102(8):833–839
  16. Bloemenkamp DG, Mali WP, Tanis BC, Rosendaal FR, van den Bosch MA, Kemmeren JM, et al. Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and the risk of peripheral arterial disease in young women. Atherosclerosis. 2002;163(1):149–156
  17. Izquierdo-Porrera AM, Gardner AW, Bradham DD, Montgomery PS, Sorkin JD, Powell CC, et al. Relationship between objective measures of peripheral arterial disease severity to self-reported quality of life in older adults with intermittent claudication. J Vasc Surg. 2005;41(4):625–630
  18. Management of peripheral arterial disease (PAD). TransAtlantic Inter-society Consensus (TASC). Section B: intermittent claudication. Eur J Vasc Endovasc Surg 2000;19(Suppl A):S47–S114.
  19. Langlois M, Duprez D, Delanghe J, De Buyzere M, Clement DL. Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation. 2001;103(14):1863–1868
  20. McDermott MM, Green D, Greenland P, Liu K, Criqui MH, Chan C, et al. Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. Am J Cardiol. 2003;92(2):194–199
  21. Santos S, Rooke TW, Bailey KR, McConnell JP, Kullo IJ. Relation of markers of inflammation (C-reactive protein, white blood cell count, and lipoprotein-associated phospholipase A2) to the ankle–brachial index. Vasc Med. 2004;9(3):171–176
  22. McDermott MM, Greenland P, Green D, Guralnik JM, Criqui MH, Liu K, et al. D-dimer inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. Circulation. 2003;107(25):3191–3198[Epub 2003 January 16]
  23. Brevetti G, Silvestro A, Di Giacomo S, Bucur R, Di Donato A, Schiano V, et al. Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. J Vasc Surg. 2003;38(2):374–379
  24. Lindholt JS, Vammen S, Lind I, Fasting H, Henneberg EW. The progression of lower limb atherosclerosis is associated with IgA antibodies against Chlamydia pneumoniae. Eur J Vasc Endovasc Surg. 1999;18(6):527–529
  25. Wiesli P, Czerwenka W, Meniconi A, Maly FE, Hoffmann U, Vetter W, et al. Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial. Circulation. 2002;105(22):2646–2652
  26. Vainas T, Stassen FR, Schurink GW, Tordoir JH, Welten RJ, van den Akker LH, et al. Secondary prevention of atherosclerosis through Chlamydia pneumoniae eradication (SPACE trial): a randomised clinical trial in patients with peripheral arterial disease. Eur J Vasc Endovasc Surg. 2005;29(4):403–411
  27. Andraws R, Berger JS, Brown DL. Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. JAMA. 2005;293(21):2641–2647
  28. Fiotti N, Giansante C, Ponte E, Delbello C, Calabrese S, Zacchi T. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis. 1999;145(1):51–60
  29. Cassar K, Bachoo P, Ford I, Greaves M, Brittenden J. Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease. Eur J Vasc Endovasc Surg. 2005;29(2):171–176
  30. Loehe F, Bittmann I, Weilbach C, Lauterjung L, Schildberg FW, Heiss MM. Chlamydia pneumoniae in atherosclerotic lesions of patients undergoing vascular surgery. Ann Vasc Surg. 2002;16(4):467–473[Epub 2002 July 8]
  31. Gutierrez J, Linares-Palomino J, Lopez-Espada C, Rodriguez M, Ros E, Piedrola G, et al. Chlamydia pneumoniae DNA in the arterial wall of patients with peripheral vascular disease. Infection. 2001;29(4):196–200
  32. Brevetti G, Piscione F, Silvestro A, Galasso G, DiDonato A, Oliva G, et al. Increased inflammatory status and higher prevalence of three-vessel coronary artery disease in patients with concomitant coronary and peripheral atherosclerosis. Thromb Haemost. 2003;89:1058–1063
  33. Ward ME. The immunobiology and immunopathology of chlamydial infections. APMIS. 1995;103:769–796

PII: S1078-5884(05)00752-5

doi: 10.1016/j.ejvs.2005.11.022

European Journal of Vascular & Endovascular Surgery
Volume 31, Issue 5 , Pages 509-515 , May 2006

Article Tools

* Image Usage & Resolution